SE7510988L - NEW PHARMACEUTICAL ACTIVE ASSOCIATIONS - Google Patents

NEW PHARMACEUTICAL ACTIVE ASSOCIATIONS

Info

Publication number
SE7510988L
SE7510988L SE7510988A SE7510988A SE7510988L SE 7510988 L SE7510988 L SE 7510988L SE 7510988 A SE7510988 A SE 7510988A SE 7510988 A SE7510988 A SE 7510988A SE 7510988 L SE7510988 L SE 7510988L
Authority
SE
Sweden
Prior art keywords
pharmaceutical active
new pharmaceutical
active associations
associations
new
Prior art date
Application number
SE7510988A
Other languages
Swedish (sv)
Inventor
L A Svensson
L M Sorenby
K I L Wetterlin
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Priority to SE7510988A priority Critical patent/SE7510988L/en
Priority to ZA765331A priority patent/ZA765331B/en
Priority to DE19762640972 priority patent/DE2640972A1/en
Priority to AT682376A priority patent/AT347427B/en
Priority to FI762660A priority patent/FI762660A/fi
Priority to SU762402852A priority patent/SU638252A3/en
Priority to NZ182165A priority patent/NZ182165A/en
Priority to AU18122/76A priority patent/AU503212B2/en
Priority to DD195022A priority patent/DD126278A5/xx
Priority to LU75916A priority patent/LU75916A1/xx
Priority to DK439776AA priority patent/DK141622B/en
Priority to FR7629467A priority patent/FR2326183A1/en
Priority to NO763345A priority patent/NO763345L/no
Priority to ES451979A priority patent/ES451979A1/en
Priority to NL7610845A priority patent/NL7610845A/en
Priority to GB7640684A priority patent/GB1542317A/en
Priority to CS766357A priority patent/CS199643B2/en
Priority to CS782253A priority patent/CS199644B2/en
Priority to BE171148A priority patent/BE846837A/en
Priority to JP51118924A priority patent/JPS5242840A/en
Publication of SE7510988L publication Critical patent/SE7510988L/en
Priority to SU772532454A priority patent/SU674669A3/en
Priority to AT108278A priority patent/AT350526B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE7510988A 1975-10-01 1975-10-01 NEW PHARMACEUTICAL ACTIVE ASSOCIATIONS SE7510988L (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
SE7510988A SE7510988L (en) 1975-10-01 1975-10-01 NEW PHARMACEUTICAL ACTIVE ASSOCIATIONS
ZA765331A ZA765331B (en) 1975-10-01 1976-09-07 Novel pharmaceutically active compounds
DE19762640972 DE2640972A1 (en) 1975-10-01 1976-09-11 AMINOAETHANOL DERIVATIVES, THE PROCESS FOR THEIR MANUFACTURING AND THE MEDICINAL PRODUCTS CONTAINING THEM
AT682376A AT347427B (en) 1975-10-01 1976-09-15 METHOD FOR PRODUCING NEW 2-AMINO-1-PHENYLAETHANOLEN- (1) AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
FI762660A FI762660A (en) 1975-10-01 1976-09-16
SU762402852A SU638252A3 (en) 1975-10-01 1976-09-22 Method of obtaining aminoethanol derivatives or salts thereof
NZ182165A NZ182165A (en) 1975-10-01 1976-09-27 Derivatives of 1-(3,5-dihydroxyphenyl)-2 aminoethanol, andpharmaceutical composition
AU18122/76A AU503212B2 (en) 1975-10-01 1976-09-27 1-(3,5-dihydroxyphenyl)-2[hydroxyalkyl)amino] ethanols and their esters
DD195022A DD126278A5 (en) 1975-10-01 1976-09-28
FR7629467A FR2326183A1 (en) 1975-10-01 1976-09-30 COMPOUNDS AND COMPOSITIONS WITH ANTIALLERGIC AND ANTIANAPHYLACTIC ACTIVITY
DK439776AA DK141622B (en) 1975-10-01 1976-09-30 Analogous process for preparing racemic or optically active 1- (3,5-dihydroxyphenyl) -2-aminoethanol derivatives or acid addition salts thereof.
LU75916A LU75916A1 (en) 1975-10-01 1976-09-30
NO763345A NO763345L (en) 1975-10-01 1976-09-30
ES451979A ES451979A1 (en) 1975-10-01 1976-09-30 Phenylethanolamine derivatives
NL7610845A NL7610845A (en) 1975-10-01 1976-09-30 NEW PHARMACOLOGICALLY ACTIVE COMPOUNDS.
GB7640684A GB1542317A (en) 1975-10-01 1976-09-30 Phenylethanolamine derivatives
CS766357A CS199643B2 (en) 1975-10-01 1976-10-01 Method of producing novel derivatives of phenylaminoethanol
CS782253A CS199644B2 (en) 1975-10-01 1976-10-01 Method of producing new derivatives of phenylaminoethanol
BE171148A BE846837A (en) 1975-10-01 1976-10-01 COMPOUNDS AND COMPOSITIONS WITH ANTIALLERGIC AND ANTIANAPHYLACTIC ACTIVITY,
JP51118924A JPS5242840A (en) 1975-10-01 1976-10-01 Novel pharmaceutically active compound
SU772532454A SU674669A3 (en) 1975-10-01 1977-10-13 Method of obtaining ethanol derivatives or salts thereof
AT108278A AT350526B (en) 1975-10-01 1978-02-15 PROCESS FOR THE PREPARATION OF NEW 2-AMINO-1-PHENYLAETHANOLS - (1) AND THE SALT THEREOF

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7510988A SE7510988L (en) 1975-10-01 1975-10-01 NEW PHARMACEUTICAL ACTIVE ASSOCIATIONS

Publications (1)

Publication Number Publication Date
SE7510988L true SE7510988L (en) 1977-04-02

Family

ID=20325688

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7510988A SE7510988L (en) 1975-10-01 1975-10-01 NEW PHARMACEUTICAL ACTIVE ASSOCIATIONS

Country Status (19)

Country Link
JP (1) JPS5242840A (en)
AT (1) AT347427B (en)
AU (1) AU503212B2 (en)
BE (1) BE846837A (en)
CS (2) CS199643B2 (en)
DD (1) DD126278A5 (en)
DE (1) DE2640972A1 (en)
DK (1) DK141622B (en)
ES (1) ES451979A1 (en)
FI (1) FI762660A (en)
FR (1) FR2326183A1 (en)
GB (1) GB1542317A (en)
LU (1) LU75916A1 (en)
NL (1) NL7610845A (en)
NO (1) NO763345L (en)
NZ (1) NZ182165A (en)
SE (1) SE7510988L (en)
SU (2) SU638252A3 (en)
ZA (1) ZA765331B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3163871D1 (en) 1980-07-09 1984-07-05 Draco Ab 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
EP0103830A3 (en) * 1982-09-22 1985-07-31 Bayer Ag Phenylethylemine derivatires as growth stimulators
US8367657B2 (en) 2003-06-17 2013-02-05 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
EP2518053A1 (en) 2006-04-03 2012-10-31 Arena Pharmaceuticals, Inc. Process for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
CN101547892B (en) 2006-12-05 2014-08-20 艾尼纳制药公司 Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof
WO2009111004A1 (en) 2008-03-04 2009-09-11 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
EP2443080A2 (en) 2009-06-18 2012-04-25 Arena Pharmaceuticals, Inc. Process for the preparation of 5-ht2c receptor agonists
WO2011153206A1 (en) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
SG188365A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Administration of lorcaserin to individuals with renal impairment
CN103189053A (en) 2010-09-01 2013-07-03 艾尼纳制药公司 Modified-release dosage forms of 5-ht2c agonists useful for weight management
KR20130138770A (en) 2010-09-01 2013-12-19 아레나 파마슈티칼스, 인크. Salts of lorcaserin with optically active acids
WO2012030957A2 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-ht2c agonists
US20150297610A1 (en) 2012-10-09 2015-10-22 Arena Pharmaceuticals, Inc. Method of weight management

Also Published As

Publication number Publication date
NL7610845A (en) 1977-04-05
ATA682376A (en) 1978-05-15
JPS5242840A (en) 1977-04-04
FR2326183A1 (en) 1977-04-29
LU75916A1 (en) 1978-05-16
CS199644B2 (en) 1980-07-31
AU503212B2 (en) 1979-08-30
DK439776A (en) 1977-04-02
DD126278A5 (en) 1977-07-06
SU674669A3 (en) 1979-07-15
DK141622B (en) 1980-05-12
AT347427B (en) 1978-12-27
FI762660A (en) 1977-04-02
DE2640972A1 (en) 1977-04-14
GB1542317A (en) 1979-03-14
CS199643B2 (en) 1980-07-31
ES451979A1 (en) 1978-01-01
AU1812276A (en) 1978-04-06
NO763345L (en) 1977-04-04
SU638252A3 (en) 1978-12-15
ZA765331B (en) 1977-08-31
NZ182165A (en) 1978-07-10
BE846837A (en) 1977-04-01

Similar Documents

Publication Publication Date Title
SE7605620L (en) PHARMACOLOGICALLY ACTIVE ASSOCIATIONS
SE7612366L (en) NEW HYDROXYBENZYLMALONIC ACID DERIVATIVES.
SE7604761L (en) NEW POLYPEPTIDER
SE7614085L (en) NEW ORGANIC ASSOCIATIONS, THEIR PREPARATION AND USE
SE7710762L (en) PHARMACOLOGICALLY ACTIVE ASSOCIATIONS
SE7600139L (en) NEW VIFENYLOXIDE DERIVATIVES
SE7510988L (en) NEW PHARMACEUTICAL ACTIVE ASSOCIATIONS
SE408266B (en) DRUG EVAPORATORS
SE7506947L (en) PHARMACOLOGICALLY ACTIVE ASSOCIATIONS
FI56525B (en) NYA KROMOGENA TROMBINSUBSTRAT
SE7702771L (en) PHARMACOLOGICALLY ACTIVE ASSOCIATIONS
SE7608478L (en) PHARMACEUTICAL
FR2326189A2 (en) PHARMACEUTICAL COMPOSITION
SE7703948L (en) NEW ANIBACTERIAL ASSOCIATIONS
SE7603563L (en) NEW THIAZOLINONES
SE7606877L (en) NEW ORGANIC ASSOCIATIONS, THEIR PREPARATION AND USE
SE7605158L (en) NEW ORGANIC ASSOCIATIONS
SE7705857L (en) PHARMACEUTICAL ACTIVE ASSOCIATIONS
SE7612565L (en) PROCEDURE FOR PREPARING NEW RIFAMYCINE ASSOCIATIONS
SE7605818L (en) NEW DIUREID ASSOCIATIONS
SE7606405L (en) NEW ORGANIC ASSOCIATIONS, THEIR PREPARATION AND USE
SE7506348L (en) HEART ACTIVE ASSOCIATIONS
SE7600480L (en) PHARMACEUTICAL USE 2-AMINOACETAMIDO-ALFA-PHENYLBENZYLIDENAMINOALK
FR2320731A1 (en) PHARMACEUTICAL COMPOSITION
BE840608A (en) NEW PHARMACEUTICAL COMPOSITIONS